Intravenous Immunoglobulin Market Size, Share, And Growth Report 2032

Intravenous Immunoglobulin Market: Size

The global Intravenous Immunoglobulin Market size was worth around USD 11.69 billion in 2023 and is predicted to grow to around USD 22.01 billion by 2032 with a compound annual growth rate (CAGR) of roughly 7.28% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the Intravenous Immunoglobulin Market on a global and regional level.

Request Free Sample

Intravenous Immunoglobulin Market: Overview

Intravenous immunoglobulin is a blood product that is prepared from the serum of about 1,000 to 10,000 donors per batch. This type of treatment is used for treating patients with antibody deficiencies. For this purpose, IVIG is used at a replacement dose of 200–400 mg/kg body weight, which is given approximately for about 3-weeks. Immunoglobulins are glycoproteins that are often produced in the blood plasma, which respond to antigens present in the body. They are obtained from the blood via fractionation and are purified for various applications.

Significant rise in the global geriatric population, increase in the number of hemophilic patients, improved technology for high production of intravenous immunoglobulin, and enhancements in the purification techniques are the major factors fueling the global intravenous immunoglobulin market. Moreover, the increasing government initiatives for treating hemophilic patients and rising cases of CIDP and hypogammaglobulinemia are also fueling the market. However, strict government regulations pertaining to intravenous immunoglobulin usage due to its harmful side-effects may hinder the market globally. Alternatively, growing per capita disposable income of people across the world, rising active role of distributors, developing advanced healthcare facilities, and increasing awareness among people are some other factors further fueling the intravenous immunoglobulin market globally.

Intravenous Immunoglobulin Market: Segmentation

The study provides a decisive view of the intravenous immunoglobulin market by component, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

Based on component, the intravenous immunoglobulin market includes IgM, IgA, IgE, IgD, and IgG.

By application, the market includes immunodeficiency diseases, Guillain-Barre syndrome, hypogammaglobulinemia, multifocal motor neuropathy, CIDP (chronic inflammatory demyelinating polyneuropathy), thrombocytopenic purpura, specific antibody deficiency, inflammatory myopathies, myasthenia gravis, and others.

Based on end-user, the market for intravenous immunoglobulin comprises hospitals, homecare settings, and clinics.

Intravenous Immunoglobulin Market: Report Scope

Intravenous Immunoglobulin Market: Regional Analysis

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

North America is likely to dominate the global intravenous immunoglobulin market, owing to the early introduction of highly developed techniques, increasing hemophilic patients due to changing lifestyle patterns, and rising disposable income of the regional population. The Asia Pacific region is anticipated to show a high rate of growth in the upcoming years, owing to the rising investments and funding by private organizations, active participation of online and offline distribution networks, increasing population, growing establishments of health clinics and hospitals in India and China, and rising number of patients suffering from hemophilic diseases.

Intravenous Immunoglobulin Market: Competitive Players

Some major players of the global intravenous immunoglobulin market are:

• LFB Biotechnologies
• Biotest
• Octapharma
• Grifols
• CSL Behring
• China Biologics Products
• Kedrion Biopharma
• BDI Pharma
• Shire
• CSL Behring

The Global Intravenous Immunoglobulin Market is segmented as follows:

Global Intravenous Immunoglobulin Market: Component Analysis

• IgG
• IgA
• IgM
• IgE
• IgD

Global Intravenous Immunoglobulin Market: Application Analysis

• Immunodeficiency Diseases
• Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
• Idiopathic Thrombocytopenic Purpura
• Hypogammaglobulinemia
• Myasthenia Gravis
• Multifocal Motor Neuropathy
• Inflammatory Myopathies
• Specific Antibody Deficiency
• Guillain-Barre Syndrome
• Others

Global Intravenous Immunoglobulin Market: End-User Analysis

• Hospitals
• Clinics
• Homecare Settings

Global Intravenous Immunoglobulin Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa